Early outcome after placement of a metallic intracoronary stent: initial Mayo Clinic experience

K N Garratt1, D R Holmes, G S Roubin

  • 1Division of Cardiovascular Diseases and Internal Medicine, University of Alabama, Birmingham, Alabama.

Insights

Coronary stents effectively treat abrupt coronary closure after angioplasty, reducing the need for bypass surgery. This metallic coil stent shows promise for high-risk and restenotic lesions, though long-term outcomes are still unknown.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) carries a risk of in-hospital coronary closure (3-7%) and subsequent myocardial infarction.
  • Disrupted coronary integrity, especially large dissections, increases the risk of acute coronary closure.
  • Coronary vascular stents offer a potential solution to alleviate acute or threatened coronary closure and reduce patient morbidity.

Purpose of the Study:

  • To evaluate the efficacy and safety of the Gianturco-Roubin coronary stent in treating acute or threatened coronary closure post-angioplasty.
  • To assess the feasibility of elective stent placement for high-risk or restenotic coronary lesions.
  • To determine the complication rates associated with coronary stent placement.

Main Methods:

  • A prospective study involving 15 patients at Mayo Clinic between October 1989 and June 1990.
  • Attempted placement of 16 balloon-expandable, flexible metallic coil (Gianturco-Roubin) coronary stents.
  • Stent placement was performed for actual/threatened abrupt closure (10 patients), high-risk lesions (1 patient), and restenotic lesions (5 patients).

Main Results:

  • Successful stent placement in 15 out of 16 attempts (94% success rate).
  • No early deaths or need for coronary artery bypass grafting.
  • Complications were uncommon and comparable to those after balloon angioplasty.
  • Stents were successfully deployed in native arteries and vein grafts for various lesion types.

Conclusions:

  • The Gianturco-Roubin metallic coil stent is effective in managing vascular disruption causing or threatening coronary closure after angioplasty.
  • Elective coronary stent placement is safe for patients with high-risk or recurrent restenotic lesions.
  • Long-term outcomes for patients receiving coronary stents remain to be determined.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...